BDKRB2 and breast cancer: Mice were infused intravenously with the B2R agonist NG291 (50 μg/kg over 5 min) or vehicle saline and simultaneously intracardiacally inoculated with 4T1-luc mammary cancer cells, which have a high propensity to form metastases, specifically in the brain [35,36].